资产负债表（Biohaven Pharmaceutical Holding Co Ltd）
| 2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|---|
| 截止日期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 报表年结日 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 |
| 原始币种 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市前 | 上市前 | 上市后 |
| 流动资产： | ||||||||
| 现金及现金等价物(元) | 248,402,000.00 | 111,697,000.00 | 147,612,000.00 | 125,031,000.00 | 204,877,000.00 | 50,668,000.00 | 23,209,000.00 | 169,065,000.00 |
| 受限制存款及现金流动(元) | - | 28,000.00 | 40,415,000.00 | 61,548,000.00 | 35,212,000.00 | - | - | - |
| 应收账款及票据(元) | - | - | - | - | - | - | - | 328,342,000.00 |
| 预付款项及其他应收款流动(元) | 35,242,000.00 | 33,936,000.00 | 27,654,000.00 | 26,400,000.00 | 20,945,000.00 | 17,910,000.00 | 14,469,000.00 | 104,891,000.00 |
| 存货(元) | - | - | - | - | - | - | - | 91,281,000.00 |
| 可收回本期税项(元) | 13,252,000.00 | 13,073,000.00 | 8,656,000.00 | 43,830,000.00 | 46,139,000.00 | - | - | - |
| 短期投资(元) | 133,417,000.00 | 128,899,000.00 | 187,503,000.00 | 262,998,000.00 | 260,464,000.00 | - | - | 433,410,000.00 |
| 流动资产其他项目(元) | 12,133,000.00 | 22,937,000.00 | 22,278,000.00 | 24,669,000.00 | 19,331,000.00 | 11,972,000.00 | 9,073,000.00 | 44,096,000.00 |
| 流动资产合计(元) | 442,446,000.00 | 310,570,000.00 | 434,118,000.00 | 544,476,000.00 | 586,968,000.00 | 80,550,000.00 | 46,751,000.00 | 1,171,085,000.00 |
| 非流动资产： | ||||||||
| 物业、厂房及设备(元) | 17,191,000.00 | 17,669,000.00 | 17,277,000.00 | 17,494,000.00 | 17,512,000.00 | 17,423,000.00 | 13,397,000.00 | 14,534,000.00 |
| 无形资产(元) | 18,400,000.00 | 18,400,000.00 | 18,400,000.00 | 18,400,000.00 | 18,400,000.00 | 18,400,000.00 | 18,400,000.00 | 55,910,000.00 |
| 商誉(元) | 1,390,000.00 | 1,390,000.00 | 1,390,000.00 | 1,390,000.00 | 1,390,000.00 | 1,390,000.00 | 1,390,000.00 | - |
| 非流动资产其他项目(元) | 33,785,000.00 | 34,707,000.00 | 35,551,000.00 | 36,761,000.00 | 37,513,000.00 | 17,883,000.00 | 18,282,000.00 | 130,188,000.00 |
| 非流动资产合计(元) | 70,766,000.00 | 72,166,000.00 | 72,618,000.00 | 74,045,000.00 | 74,815,000.00 | 55,096,000.00 | 51,469,000.00 | 200,632,000.00 |
| 总资产(元) | 513,212,000.00 | 382,736,000.00 | 506,736,000.00 | 618,521,000.00 | 661,783,000.00 | 135,646,000.00 | 98,220,000.00 | 1,371,717,000.00 |
| 流动负债： | ||||||||
| 应付账款及票据(元) | 15,577,000.00 | 9,515,000.00 | 12,039,000.00 | 14,456,000.00 | 10,703,000.00 | 4,731,000.00 | 6,377,000.00 | 56,202,000.00 |
| 其他应付款及应计费用(元) | 39,846,000.00 | 52,634,000.00 | 35,393,000.00 | 38,002,000.00 | 44,106,000.00 | 23,704,000.00 | 59,473,000.00 | 457,412,000.00 |
| 流动负债其他项目(元) | - | 28,000.00 | 40,415,000.00 | 61,548,000.00 | 35,212,000.00 | - | - | 62,500,000.00 |
| 流动负债合计(元) | 55,423,000.00 | 62,177,000.00 | 87,847,000.00 | 114,006,000.00 | 90,021,000.00 | 28,435,000.00 | 65,850,000.00 | 576,114,000.00 |
| 非流动负债： | ||||||||
| 长期债务(元) | - | - | - | - | - | - | - | 634,106,000.00 |
| 融资租赁负债非流动(元) | 27,569,000.00 | 28,286,000.00 | 29,115,000.00 | 29,760,000.00 | 30,581,000.00 | - | - | - |
| 衍生工具负债非流动(元) | - | - | - | - | - | - | - | 9,120,000.00 |
| 非流动负债其他项目(元) | 2,245,000.00 | 2,267,000.00 | 2,519,000.00 | 2,497,000.00 | 2,410,000.00 | 6,995,000.00 | 7,372,000.00 | 618,790,000.00 |
| 非流动负债合计(元) | 29,814,000.00 | 30,553,000.00 | 31,634,000.00 | 32,257,000.00 | 32,991,000.00 | 6,995,000.00 | 7,372,000.00 | 1,262,016,000.00 |
| 总负债(元) | 85,237,000.00 | 92,730,000.00 | 119,481,000.00 | 146,263,000.00 | 123,012,000.00 | 35,430,000.00 | 73,222,000.00 | 1,838,130,000.00 |
| 股东权益： | ||||||||
| 普通股(元) | 887,528,000.00 | 618,761,000.00 | 617,510,000.00 | 616,246,000.00 | 615,742,000.00 | - | - | 2,112,686,000.00 |
| 股本溢价(元) | 39,804,000.00 | 25,623,000.00 | 21,687,000.00 | 17,462,000.00 | 13,869,000.00 | - | - | 129,580,000.00 |
| 留存收益(元) | -499,292,000.00 | -354,536,000.00 | -251,962,000.00 | -161,616,000.00 | -91,124,000.00 | - | - | -2,702,154,000.00 |
| 累计其他全面收益(元) | -65,000.00 | 158,000.00 | 20,000.00 | 166,000.00 | 284,000.00 | - | - | -2,398,000.00 |
| 归属于母公司股东权益其他项目(元) | - | - | - | - | - | 100,216,000.00 | 24,998,000.00 | - |
| 归属于母公司股东权益(元) | 427,975,000.00 | 290,006,000.00 | 387,255,000.00 | 472,258,000.00 | 538,771,000.00 | 100,216,000.00 | 24,998,000.00 | -462,286,000.00 |
| 少数股东权益(元) | - | - | - | - | - | - | - | -4,127,000.00 |
| 股东权益合计(元) | 427,975,000.00 | 290,006,000.00 | 387,255,000.00 | 472,258,000.00 | 538,771,000.00 | 100,216,000.00 | 24,998,000.00 | -466,413,000.00 |
| 负债及股东权益合计(元) | 513,212,000.00 | 382,736,000.00 | 506,736,000.00 | 618,521,000.00 | 661,783,000.00 | 135,646,000.00 | 98,220,000.00 | 1,371,717,000.00 |
| 公告日期 | 2024-02-29 | 2023-11-14 | 2023-07-31 | 2023-05-12 | 2023-03-23 | 2022-11-09 | 2022-10-18 | 2022-05-10 |
| 会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 |
| 审计意见 | ||||||||
| 核数师 |